Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Artificial Intelligence
Life Science
Biopharma
Oncology
Health Care
Pharmaceuticals
Personalized Medicine
Dosage Optimization
Digital Healthcare
Licensing/Distribution
Clinical Development
Therapeutics
Infectious Diseases
Drug Development
Machine Learning
Date founded
2016
Funding rounds raised
Total raised
$5M
from 2 investors over 2 rounds
K
KYAN Therapeutics raised $5M on October 26, 2022
Investors: Altara Ventures and K3 Ventures